Market Overview

UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, Raises PT on Stryker Corporation

Share:
Related SYK
Earnings Scheduled For July 27, 2017
FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health

In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating on Stryker Corporation (NYSE: SYK), and raised its price target from $57.00 to $67.00.

BofA Merrill Lynch noted, “Over the last 10 years, SYK has traded at a 33% P/E premium to the S&P, but since 2008, the average premium has been reduced to below 20%. Our PO assumes SYK's premium increases back up to the 20% area as investors get more comfortable with SYK's ability to maintain and grow margins despite a tough environment and as investors gain confidence that the weak economy is not on the verge of driving another downtick in top-line growth.”

Stryker Corporation closed on Tuesday at $55.81.

Latest Ratings for SYK

DateFirmActionFromTo
Jun 2017Cantor FitzgeraldInitiates Coverage OnNeutral
May 2017Goldman SachsInitiates Coverage OnNeutral
Dec 2016UBSUpgradesNeutralBuy

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Price Target Analyst Ratings

 

Related Articles (SYK)

View Comments and Join the Discussion!